Skip to content

Advertisement

Cancer & Metabolism

Erratum
Open Access

Erratum to: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia

  • Surendra K Shukla1,
  • Teklab Gebregiworgis2,
  • Vinee Purohit1, 3,
  • Nina V Chaika1,
  • Venugopal Gunda1,
  • Prakash Radhakrishnan1,
  • Kamiya Mehla1,
  • Iraklis I Pipinos4, 5,
  • Robert Powers2,
  • Fang Yu6 and
  • Pankaj K Singh1, 3, 7, 8Email author
Cancer & Metabolism20142:23

https://doi.org/10.1186/2049-3002-2-22

©  Shukla et al.; licensee BioMed Central Ltd. 2014

Received: 24 September 2014

Accepted: 24 September 2014

Published: 29 September 2014

The original article was published in Cancer & Metabolism 2014 2:18

Keywords

AcetateCancer CellCancer ResearchQuantitative AnalysisMetabolic Disease

Correction

After publication of this Research Article[1], we noticed we had included an incorrect image in Figure 1D in the panel for LiAcAc 20 mM. A corrected Figure 1 is included here.
Figure 1
Figure 1

Ketone bodies inhibit growth and induce apoptosis in pancreatic cancer cell lines. Capan1 (A) and S2-013 (B) cells were treated with different concentrations of sodium-3-hydroxybutyrate (NaHB) and lithium acetoacetate (LiAcAc) for 72 h, and cell viability was determined by MTT assay. Bar represents percent viability under indicated treatments relative to treatment with solvent control. Representative bright-field images of Capan1 (C) and S2-013 (D) cells under treatment with 10- and 20-mM concentrations of NaHB and LiAcAc for 72 h. (E) Multiple pancreatic cancer cell lines were treated with 10- and 20-mM concentrations of NaHB and LiAcAc for 72 h, and relative cell viability determined by MTT assay is plotted in the bar charts. (F) Capan1 and S2-013 cells treated with 10- and 20-mM concentrations of sodium-3-hydroxybutyrate and lithium acetoacetate for 48 h and the relative caspase 3/7 activity are plotted. Values represented are mean ± SEM. *P<0.05; **P<0.01.

Notes

Declarations

Authors’ Affiliations

(1)
The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA
(2)
Department of Chemistry, University of Nebraska—Lincoln, USA
(3)
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, USA
(4)
Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, USA
(5)
Department of Surgery, University of Nebraska Medical Center, Omaha, USA
(6)
Department of Biostatistics, University of Nebraska Medical Center, Omaha, USA
(7)
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, USA
(8)
Department of Genetic Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, USA

References

  1. Shukla SK, Gebregiworgis T, Purohit V, Chaika NV, Gunda V, Radhakrishnan P, Mehla K, Pipinos II, Powers R, Yu F, Singh PK: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Canc Metabol. 2014, 2: 18-10.1186/2049-3002-2-18.View ArticleGoogle Scholar

Copyright

© Shukla et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement

Cancer & Metabolism

ISSN: 2049-3002